West Pharmaceutical Services, Inc. (WST): Price and Financial Metrics


West Pharmaceutical Services, Inc. (WST): $345.33

1.55 (+0.45%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

WST POWR Grades


  • WST scores best on the Sentiment dimension, with a Sentiment rank ahead of 97.92% of US stocks.
  • WST's strongest trending metric is Value; it's been moving up over the last 31 weeks.
  • WST ranks lowest in Momentum; there it ranks in the 16th percentile.

WST Stock Summary

  • WST has a market capitalization of $24,799,595,877 -- more than approximately 89.91% of US stocks.
  • The price/operating cash flow metric for West Pharmaceutical Services Inc is higher than 90.85% of stocks in our set with a positive cash flow.
  • In terms of volatility of its share price, WST is more volatile than only 9.61% of stocks we're observing.
  • Stocks that are quantitatively similar to WST, based on their financial statements, market capitalization, and price volatility, are LOGI, QRVO, MKTX, BR, and TRMB.
  • Visit WST's SEC page to see the company's official filings. To visit the company's web site, go to www.westpharma.com.

WST Price Target

For more insight on analysts targets of WST, see our WST price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $351.60 Average Broker Recommendation 1.5 (Moderate Buy)

WST Stock Price Chart Interactive Chart >

Price chart for WST

WST Price/Volume Stats

Current price $345.33 52-week high $349.29
Prev. close $343.78 52-week low $197.72
Day low $340.32 Volume 218,800
Day high $345.42 Avg. volume 447,659
50-day MA $323.93 Dividend yield 0.2%
200-day MA $292.37 Market Cap 25.49B

West Pharmaceutical Services, Inc. (WST) Company Bio


West Pharmaceutical Services develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The company was founded in 1923 and is based in Exton, Pennsylvania.

WST Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$345.33$89.31 -73%

Below please find a table outlining a discounted cash flow forecast for WST, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that West Pharmaceutical Services Inc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for WST, they are:

  • The company's debt burden, as measured by earnings divided by interest payments, is 63.88; that's higher than 89.06% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet reveals debt to be 1% of the company's capital (with equity being the remaining amount). Approximately just 8.25% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • WST's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 55.59% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-74%
1%-73%
2%-73%
3%-73%
4%-73%
5%-72%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as WST, try NVST, MD, MTD, HSIC, and ILMN.


WST Latest News Stream


Event/Time News Detail
Loading, please wait...

WST Latest Social Stream


Loading social stream, please wait...

View Full WST Social Stream

Latest WST News From Around the Web

Below are the latest news stories about West Pharmaceutical Services Inc that investors may wish to consider to help them evaluate WST as an investment opportunity.

Is There Now An Opportunity In West Pharmaceutical Services, Inc. (NYSE-WST)?

Is There Now An Opportunity In West Pharmaceutical Services, Inc. (NYSE:WST)? Yahoo Finance

Yahoo Finance | June 10, 2021

We Think West Pharmaceutical Services (NYSE:WST) Might Have The DNA Of A Multi-Bagger

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

Yahoo | June 8, 2021

Is West Pharmaceutical (WST) a Great Growth Stock?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider West Pharmaceutical (WST).

Yahoo | June 8, 2021

Align Technology (ALGN) Launches New Features in iTero Family

Align Technology's (ALGN) iTero Workflow 2.0 software and iTero Element 5D Imaging system auto-upload functionality to drive innovation in digital orthodontics and restorative dentistry.

Yahoo | June 7, 2021

3 Reasons Growth Investors Will Love West Pharmaceutical (WST)

3 Reasons Growth Investors Will Love West Pharmaceutical (WST) Yahoo Finance

Yahoo Finance | June 1, 2021

Read More 'WST' Stories Here

WST Price Returns

1-mo 5.19%
3-mo 26.05%
6-mo 30.50%
1-year 72.43%
3-year 254.01%
5-year 366.65%
YTD 22.03%
2020 89.05%
2019 54.13%
2018 -0.08%
2017 17.02%
2016 41.87%

WST Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full WST Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8565 seconds.